New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
07:27 EDTAMAGAMAG Pharmaceuticals upgraded to Outperform from Market Perform at Leerink
Leerink upgraded AMAG Pharmaceuticals on expectations Feraheme sales estimates are now achievable and label expansion can drive upside. The firm raised its price target for shares to $19 from $17.
News For AMAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
13:10 EDTAMAGAMAG Pharmaceuticals price target raised to $39 from $35 at Leerink
Subscribe for More Information
07:19 EDTAMAGAMAG Pharmaceuticals reports Q3 EPS 6c, consensus (8c)
Reports Q3 revenue $25.5M, consensus $26.26M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use